The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Appoint Michael N. Needle, M.D., Chief Medical Officer
The Multiple Myeloma Research Foundation (MMRF) Presents Study Design for Landmark Trial Focused on Genomic Analysis at the AACR Annual Meeting
The Multiple Myeloma Research Foundation (MMRF) and Translational Genomics Research Institute Announce Innovative Molecular Profiling and Biobanking Collaboration for Landmark Multiple Myeloma Study
The Multiple Myeloma Research Foundation (MMRF) Releases White Paper Outlining the Increasingly Important Role of Non-Profit Organizations in Drug Development
Multiple Myeloma Research Consortium (MMRC) Opens Record-Breaking Number of Trials in 2011 to Advance Multiple Myeloma Treatments
Multiple Myeloma Research Consortium (MMRC) Honors Dr. Ravi Vij, Washington University with 2011 Center of the Year Award
The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study
Multiple Myeloma Research Consortium (MMRC) Presents New Data Affirming Success in Accelerating Drug Development Timelines
Multiple Myeloma Research Consortium to Present Data in Eight Oral or Poster Sessions at 53rd American Society of Hematology (ASH) Annual Meeting
Multiple Myeloma Research Consortium (MMRC) Welcomes the Barbara Ann Karmanos Cancer Institute as Member Institution
Multiple Myeloma Research Foundation (MMRF) Announces Millennium as First Industry Partner in Innovative Collaboration to Advance Personalized Medicine for Multiple Myeloma
Multiple Myeloma Research Foundation (MMRF) Announces First Patient Enrolled in Landmark 1000-Patient Study, with Four World-Class Cancer Centers as First Clinical Sites
Tragara Pharmaceuticals and the Multiple Myeloma Research Foundation Initiate Phase I Clinical Study of TG02 in Multiple Myeloma Patients
MMRF Announces Launch of Carfilzomib Expanded Access Program for Patients with Relapsed and Refractory Multiple Myeloma in Partnership with Onyx Pharmaceuticals
Multiple Myeloma Research Foundation (MMRF) and Astellas Pharma Global Development Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients
Multiple Myeloma Research Foundation Announces Publication of First Whole-Genome Sequence Analysis for Multiple Myeloma
The Multiple Myeloma Research Foundation (MMRF) to Host Clinical Insights Patient Symposium in Collaboration with the John Theurer Cancer Center
Multiple Myeloma Research Foundation (MMRF) and Synta Pharmaceuticals Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients
Multiple Myeloma Research Foundation (MMRF) Saddened by Loss of Dear Friend and Former Board Member Bob DeBaun
Multiple Myeloma Research Consortium (MMRC) Welcomes Baylor Charles A. Sammons Cancer Center at Dallas, Sarah Cannon Research Institute, and Virginia Cancer Specialists as Member Institutions
Multiple Myeloma Research Consortium (MMRC) Honors University of Michigan with 2010 Center of the Year Award
Intellikine and the Multiple Myeloma Research Consortium Initiate Phase I Trial of Targeted Drug INK128
Multiple Myeloma Research Foundation (MMRF) Welcomes Nodality President and CEO David Parkinson, M.D. to Board of Directors
Astex and Multiple Myeloma Research Consortium (MMRC) Announce Start of Phase II Clinical Study of AT7519 in Multiple Myeloma
Multiple Myeloma Research Consortium (MMRC) and Mount Sinai School of Medicine Announce Research Collaboration
Multiple Myeloma Research Consortium (MMRC) Helps to Advance Clinical Development of Carfilzomib
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data from Phase 2b Study
Multiple Myeloma Research Consortium (MMRC) Plays Critical Role in Advancing Carfilzomib
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data from Phase 2b Study
Multiple Myeloma Research Consortium (MMRC) Announces Data Presentations at 46th Annual American Society of Clinical Oncology (ASCO) Annual Meeting
Multiple Myeloma Research Consortium (MMRC) Genomics Initiative Provides First In-depth Look at Multiple Myeloma Genome
Multiple Myeloma Research Consortium (MMRC) Initiates Phase IB/II Clinical Trial of Treanda® in Combination with Revlimid® and Dexamethasone in Patients with Relapsed Multiple Myeloma
- Norwalk, Conn. April 9, 2012
The Multiple Myeloma Research Foundation (MMRF) Presents Study Design for Landmark Trial Focused on Genomic Analysis at the AACR Annual Meeting
- Norwalk, Conn. April 3, 2012
The Multiple Myeloma Research Foundation (MMRF) and Translational Genomics Research Institute Announce Innovative Molecular Profiling and Biobanking Collaboration for Landmark Multiple Myeloma Study
- Norwalk, Conn. and Phoenix, Ariz. April 2, 2012
The Multiple Myeloma Research Foundation (MMRF) Releases White Paper Outlining the Increasingly Important Role of Non-Profit Organizations in Drug Development
- Norwalk, Conn. January 19, 2012
Multiple Myeloma Research Consortium (MMRC) Opens Record-Breaking Number of Trials in 2011 to Advance Multiple Myeloma Treatments
- Norwalk, Conn. December 22, 2011
Multiple Myeloma Research Consortium (MMRC) Honors Dr. Ravi Vij, Washington University with 2011 Center of the Year Award
- Norwalk, Conn. December 21, 2011
The Multiple Myeloma Research Foundation (MMRF) Announces Four Leading Academic Cancer Centers as Clinical Sites for Landmark Study
- Norwalk, Conn. December 19, 2011
Multiple Myeloma Research Consortium (MMRC) Presents New Data Affirming Success in Accelerating Drug Development Timelines
- Norwalk, Conn. December 13, 2011
Multiple Myeloma Research Consortium to Present Data in Eight Oral or Poster Sessions at 53rd American Society of Hematology (ASH) Annual Meeting
- Norwalk, Conn. December 6, 2011
Multiple Myeloma Research Consortium (MMRC) Welcomes the Barbara Ann Karmanos Cancer Institute as Member Institution
- Norwalk, Conn. December 2, 2011
Multiple Myeloma Research Foundation (MMRF) Announces Millennium as First Industry Partner in Innovative Collaboration to Advance Personalized Medicine for Multiple Myeloma
- Norwalk, Conn. September 29, 2011
Multiple Myeloma Research Foundation (MMRF) Announces First Patient Enrolled in Landmark 1000-Patient Study, with Four World-Class Cancer Centers as First Clinical Sites
- Norwalk, Conn. September 20, 2011
Tragara Pharmaceuticals and the Multiple Myeloma Research Foundation Initiate Phase I Clinical Study of TG02 in Multiple Myeloma Patients
- San Diego, Calif. and Norwalk, Conn. September 14, 2011
MMRF Announces Launch of Carfilzomib Expanded Access Program for Patients with Relapsed and Refractory Multiple Myeloma in Partnership with Onyx Pharmaceuticals
- Norwalk, Conn. August 3, 2011
Multiple Myeloma Research Foundation (MMRF) and Astellas Pharma Global Development Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients
- Norwalk, Conn. and Deerfield, Ill. May 5, 2011
Multiple Myeloma Research Foundation Announces Publication of First Whole-Genome Sequence Analysis for Multiple Myeloma
- Norwalk, Conn. March 23, 2011
The Multiple Myeloma Research Foundation (MMRF) to Host Clinical Insights Patient Symposium in Collaboration with the John Theurer Cancer Center
- Norwalk, Conn. and Hackensack, N.J. March 16, 2011
Multiple Myeloma Research Foundation (MMRF) and Synta Pharmaceuticals Enter into Joint Collaboration to Accelerate Drug Development for Myeloma Patients
- Norwalk, Conn. and Lexington, Mass. January 12, 2011
Multiple Myeloma Research Foundation (MMRF) Saddened by Loss of Dear Friend and Former Board Member Bob DeBaun
- Norwalk, Conn. December 30, 2010
Multiple Myeloma Research Consortium (MMRC) Welcomes Baylor Charles A. Sammons Cancer Center at Dallas, Sarah Cannon Research Institute, and Virginia Cancer Specialists as Member Institutions
- Norwalk, Conn. December 22, 2010
Multiple Myeloma Research Consortium (MMRC) Honors University of Michigan with 2010 Center of the Year Award
- Norwalk, Conn. December 3, 2010
Intellikine and the Multiple Myeloma Research Consortium Initiate Phase I Trial of Targeted Drug INK128
- La Jolla, Calif. November 30, 2010
Multiple Myeloma Research Foundation (MMRF) Welcomes Nodality President and CEO David Parkinson, M.D. to Board of Directors
- Norwalk, Conn. September 8, 2010
Astex and Multiple Myeloma Research Consortium (MMRC) Announce Start of Phase II Clinical Study of AT7519 in Multiple Myeloma
- Cambridge, UK and Norwalk, Conn., August, 12 2010
Multiple Myeloma Research Consortium (MMRC) and Mount Sinai School of Medicine Announce Research Collaboration
- Norwalk, Conn. and New York, NY, August 2, 2010
Multiple Myeloma Research Consortium (MMRC) Helps to Advance Clinical Development of Carfilzomib
- Norwalk, Conn., July 28, 2010
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data from Phase 2b Study
- Emeryville, CA, July 26, 2010
Multiple Myeloma Research Consortium (MMRC) Plays Critical Role in Advancing Carfilzomib
- Norwalk, Conn., Jul. 28, 2010
Onyx Pharmaceuticals Announces Positive Top-Line Carfilzomib Data from Phase 2b Study
- Emeryville, CA, July 26, 2010
Multiple Myeloma Research Consortium (MMRC) Announces Data Presentations at 46th Annual American Society of Clinical Oncology (ASCO) Annual Meeting
- Norwalk, Conn., Jun. 1, 2010
Multiple Myeloma Research Consortium (MMRC) Genomics Initiative Provides First In-depth Look at Multiple Myeloma Genome
- Norwalk, Conn., Apr. 20, 2010
Multiple Myeloma Research Consortium (MMRC) Initiates Phase IB/II Clinical Trial of Treanda® in Combination with Revlimid® and Dexamethasone in Patients with Relapsed Multiple Myeloma
- Norwalk, Conn., Apr. 6, 2010
